Cargando…
Virus-Like Particles-Based Mucosal Nanovaccines
Virus-like particles (VLPs) are protein complexes that resemble a virus and constitute highly immunogenic entities as they mimic the pathogen at an important degree. Among nanovaccines, those based on VLPs are the most successful thus far with some formulations already commercialized (e.g., those ag...
Autores principales: | Rosales-Mendoza, Sergio, González-Ortega, Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120988/ http://dx.doi.org/10.1007/978-3-030-31668-6_10 |
Ejemplares similares
-
Pulmonary delivery of mucosal nanovaccines
por: Tang, Wei, et al.
Publicado: (2021) -
Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
por: Nooraei, Saghi, et al.
Publicado: (2021) -
Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf
por: McGill, Jodi L., et al.
Publicado: (2018) -
Recent progress in application of nanovaccines for enhancing mucosal immune responses
por: Du, Guangsheng, et al.
Publicado: (2023) -
Mucosal delivery of nanovaccine strategy against COVID-19 and its variants
por: Lee, Junwoo, et al.
Publicado: (2023)